CORCEPT THERAPEUTICS INC's ticker is CORT and the CUSIP is 218352102. A total of 215 filers reported holding CORCEPT THERAPEUTICS INC in Q4 2021. The put-call ratio across all filers is 0.42 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2022 | $751,775 | +252.9% | 37,015 | +345.5% | 0.00% | – |
| Q3 2022 | $213,000 | -58.2% | 8,309 | -67.9% | 0.00% | – |
| Q3 2021 | $510,000 | +0.6% | 25,899 | -14.2% | 0.00% | – |
| Q2 2020 | $507,000 | -58.3% | 30,170 | -70.5% | 0.00% | – |
| Q1 2020 | $1,216,000 | -49.7% | 102,209 | -48.8% | 0.00% | -100.0% |
| Q4 2019 | $2,416,000 | +358.4% | 199,628 | +344.3% | 0.00% | – |
| Q1 2019 | $527,000 | -1.7% | 44,926 | +31.7% | 0.00% | – |
| Q2 2018 | $536,000 | -80.7% | 34,125 | -79.8% | 0.00% | -100.0% |
| Q1 2018 | $2,781,000 | -57.1% | 169,050 | -52.9% | 0.00% | 0.0% |
| Q4 2017 | $6,486,000 | -7.5% | 359,145 | -1.2% | 0.00% | -50.0% |
| Q3 2017 | $7,013,000 | +126.9% | 363,363 | +38.7% | 0.00% | +100.0% |
| Q2 2017 | $3,091,000 | +131.4% | 261,933 | +114.8% | 0.00% | – |
| Q1 2017 | $1,336,000 | +161.4% | 121,948 | +73.3% | 0.00% | – |
| Q4 2016 | $511,000 | – | 70,351 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| INGALLS & SNYDER LLC | 6,911,376 | $155,644,000 | 6.95% |
| Parallel Advisors, LLC | 1,944,319 | $47,014,000 | 1.86% |
| TANAKA CAPITAL MANAGEMENT INC | 39,289 | $885,000 | 1.79% |
| S&T BANK/PA | 508,546 | $11,452,000 | 1.73% |
| Bridge City Capital, LLC | 83,967 | $1,891,000 | 0.88% |
| Birchview Capital, LP | 50,000 | $1,126,000 | 0.81% |
| Quantedge Capital Pte Ltd | 113,012 | $2,545,000 | 0.75% |
| FAS Wealth Partners, Inc. | 289,625 | $6,522,000 | 0.61% |
| AJ WEALTH STRATEGIES, LLC | 396,029 | $8,919,000 | 0.44% |
| TRUSTCORE FINANCIAL SERVICES, LLC | 208,806 | $4,702,000 | 0.41% |